• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓系来源抑制细胞诱导 T 细胞耐受的机制。

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

机构信息

Department of Immunology, H Lee Moffitt Cancer Center, University of South Florida, Tampa, FL 33612, USA.

出版信息

J Immunol. 2010 Mar 15;184(6):3106-16. doi: 10.4049/jimmunol.0902661. Epub 2010 Feb 8.

DOI:10.4049/jimmunol.0902661
PMID:20142361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832724/
Abstract

Ag-specific T cell tolerance plays a critical role in tumor escape. Recent studies implicated myeloid-derived suppressor cells (MDSCs) in the induction of CD8(+) T cell tolerance in tumor-bearing hosts. However, the mechanism of this phenomenon remained unclear. We have found that incubation of Ag-specific CD8(+) T cells, with peptide-loaded MDSCs, did not induce signaling downstream of TCR. However, it prevented subsequent signaling from peptide-loaded dendritic cells. Using double TCR transgenic CD8(+) T cells, we have demonstrated that MDSC induced tolerance to only the peptide, which was presented by MDSCs. T cell response to the peptide specific to the other TCR was not affected. Incubation of MDSCs with Ag-specific CD8(+) T cells caused nitration of the molecules on the surface of CD8(+) T cells, localized to the site of physical interaction between MDSC and T cells, which involves preferentially only TCR specific for the peptide presented by MDSCs. Postincubation with MDSCs, only nitrotyrosine-positive CD8(+) T cells demonstrated profound nonresponsiveness to the specific peptide, whereas nitrotyrosine-negative CD8(+) T cells responded normally to that stimulation. MDSCs caused dissociation between TCR and CD3zeta molecules, disrupting TCR complexes on T cells. Thus, these data describe a novel mechanism of Ag-specific CD8(+) T cell tolerance in cancer.

摘要

抗原特异性 T 细胞耐受在肿瘤逃逸中起着关键作用。最近的研究表明,髓系来源的抑制细胞(MDSCs)在肿瘤宿主中诱导 CD8(+)T 细胞耐受中起作用。然而,这种现象的机制尚不清楚。我们发现,用负载肽的 MDSC 孵育抗原特异性 CD8(+)T 细胞不会诱导 TCR 下游的信号转导。然而,它阻止了随后来自负载肽的树突状细胞的信号转导。使用双 TCR 转基因 CD8(+)T 细胞,我们已经证明 MDSC 仅诱导对由 MDSC 呈递的肽的耐受。对另一个 TCR 特异性肽的 T 细胞反应不受影响。MDSC 与抗原特异性 CD8(+)T 细胞孵育会导致 CD8(+)T 细胞表面分子的硝化,这些分子定位于 MDSC 和 T 细胞之间物理相互作用的部位,这主要涉及仅针对由 MDSC 呈递的肽的 TCR。与 MDSC 孵育后,只有硝基酪氨酸阳性的 CD8(+)T 细胞对特定肽表现出明显的无反应性,而硝基酪氨酸阴性的 CD8(+)T 细胞对该刺激正常反应。MDSC 导致 TCR 和 CD3zeta 分子分离,破坏 T 细胞上的 TCR 复合物。因此,这些数据描述了癌症中抗原特异性 CD8(+)T 细胞耐受的一种新机制。

相似文献

1
Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.髓系来源抑制细胞诱导 T 细胞耐受的机制。
J Immunol. 2010 Mar 15;184(6):3106-16. doi: 10.4049/jimmunol.0902661. Epub 2010 Feb 8.
2
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.炎症性肠病中的髓源性抑制细胞:一种新的免疫调节途径。
Gastroenterology. 2008 Sep;135(3):871-81, 881.e1-5. doi: 10.1053/j.gastro.2008.06.032. Epub 2008 Jun 12.
3
Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.在 IL-2/αCD40 治疗期间,肿瘤微环境中的调节性 T 细胞和髓源性抑制细胞经历 Fas 依赖性细胞死亡。
J Immunol. 2014 Jun 15;192(12):5821-9. doi: 10.4049/jimmunol.1400404. Epub 2014 May 7.
4
Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.抗原特异性 CD4(+) T 细胞通过 MHC Ⅱ类分子逆向信号调节肿瘤中髓系来源抑制细胞的功能。
Cancer Res. 2012 Feb 15;72(4):928-38. doi: 10.1158/0008-5472.CAN-11-2863. Epub 2012 Jan 11.
5
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.肿瘤诱导的髓系来源抑制性细胞亚群对不同的 CD8+T 细胞激活事件发挥抑制或刺激作用。
Eur J Immunol. 2013 Nov;43(11):2930-42. doi: 10.1002/eji.201343349. Epub 2013 Aug 25.
6
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.抗原识别改变是癌症中CD8 + T细胞耐受的一种机制。
Nat Med. 2007 Jul;13(7):828-35. doi: 10.1038/nm1609. Epub 2007 Jul 1.
7
γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance.γδT 细胞驱动髓源性抑制细胞介导的乙型肝炎病毒诱导免疫耐受中的 CD8+T 细胞耗竭。
J Immunol. 2014 Aug 15;193(4):1645-53. doi: 10.4049/jimmunol.1303432. Epub 2014 Jul 11.
8
Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.低效的交叉呈递限制了CD8 + T细胞对次要肿瘤抗原表位的反应。
J Immunol. 2005 Jul 15;175(2):700-12. doi: 10.4049/jimmunol.175.2.700.
9
Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.未成熟髓样树突状细胞系的抗原呈递在体内不会导致CTL缺失,但会产生可恢复完全效应功能的CD8+ 中央记忆样T细胞。
J Immunol. 2005 Jul 15;175(2):855-63. doi: 10.4049/jimmunol.175.2.855.
10
Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.髓系来源的抑制细胞可预防小鼠模型中的 1 型糖尿病。
J Immunol. 2010 Nov 15;185(10):5828-34. doi: 10.4049/jimmunol.0903636. Epub 2010 Oct 18.

引用本文的文献

1
Multi-omics identification of a polyamine metabolism related signature for hepatocellular carcinoma and revealing tumor microenvironment characteristics.多组学鉴定肝细胞癌中与多胺代谢相关的特征并揭示肿瘤微环境特征
Front Immunol. 2025 Apr 22;16:1570378. doi: 10.3389/fimmu.2025.1570378. eCollection 2025.
2
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy.中性粒细胞及基于中性粒细胞的抗癌治疗药物递送系统
Cancers (Basel). 2025 Apr 5;17(7):1232. doi: 10.3390/cancers17071232.
3
Do The Inflammatory Cells In The Blood And Tissues Have Predictive And Prognostic Value In Benign, Premalignant And Malignant Lesions Of The Larynx?血液和组织中的炎性细胞在喉良性、癌前和恶性病变中具有预测和预后价值吗?
Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):143-148. doi: 10.1007/s12070-024-05127-3. Epub 2024 Oct 15.
4
Recent advances in the role of high-salt diet in anti- and pro-cancer progression.高盐饮食在抗癌和促癌进展中作用的最新进展。
Front Immunol. 2025 Jan 29;16:1542157. doi: 10.3389/fimmu.2025.1542157. eCollection 2025.
5
Arginine metabolism in myeloid cells in health and disease.健康与疾病状态下髓系细胞中的精氨酸代谢
Semin Immunopathol. 2025 Jan 25;47(1):11. doi: 10.1007/s00281-025-01038-9.
6
The Role of the Tumor Microenvironment in T-Cell Redirecting Therapies of Large B-Cell Lymphoma: Lessons Learned from CAR-T to Bispecific Antibodies.肿瘤微环境在大B细胞淋巴瘤T细胞重定向疗法中的作用:从嵌合抗原受体T细胞疗法到双特异性抗体的经验教训
Cancers (Basel). 2025 Jan 20;17(2):317. doi: 10.3390/cancers17020317.
7
Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.解析 D2/GPR18 信号增强单核细胞来源的髓系抑制细胞的功能,减轻腹主动脉瘤的形成。
FASEB J. 2024 Sep 30;38(18):e70067. doi: 10.1096/fj.202400414RRR.
8
Targeting amino acid-metabolizing enzymes for cancer immunotherapy.针对氨基酸代谢酶的癌症免疫疗法。
Front Immunol. 2024 Aug 14;15:1440269. doi: 10.3389/fimmu.2024.1440269. eCollection 2024.
9
Tumor-associated CD8T cell tolerance induced by erythroid progenitor cells.红细胞祖细胞诱导的肿瘤相关 CD8+T 细胞耐受。
Front Immunol. 2024 May 10;15:1381919. doi: 10.3389/fimmu.2024.1381919. eCollection 2024.
10
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.了解胶质瘤的免疫抑制微环境:机制见解和临床观点。
J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7.

本文引用的文献

1
Myeloid-derived suppressor cells as regulators of the immune system.髓源性抑制细胞作为免疫系统的调节因子。
Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506.
2
Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor.外周CD8 + T细胞对自身蛋白的耐受性在T细胞受体处受到近端调节。
Immunity. 2008 May;28(5):662-74. doi: 10.1016/j.immuni.2008.03.012.
3
Signaling defects in anti-tumor T cells.抗肿瘤T细胞中的信号缺陷。
Immunol Rev. 2008 Apr;222:192-205. doi: 10.1111/j.1600-065X.2008.00606.x.
4
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.鉴定具有不同T细胞抑制活性的离散肿瘤诱导的髓源性抑制细胞亚群。
Blood. 2008 Apr 15;111(8):4233-44. doi: 10.1182/blood-2007-07-099226. Epub 2008 Feb 13.
5
Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors.优化的DNA疫苗可特异性诱导针对原发性乳腺肿瘤的治疗性CD8 T细胞反应。
Cancer Immunol Immunother. 2008 Nov;57(11):1695-703. doi: 10.1007/s00262-008-0465-x. Epub 2008 Feb 6.
6
Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.CD8+肿瘤浸润性T细胞中近端T细胞受体信号传导和裂解功能的抑制
Cancer Res. 2007 Dec 1;67(23):11447-54. doi: 10.1158/0008-5472.CAN-07-1441.
7
The adaptive immune response to sporadic cancer.对散发性癌症的适应性免疫反应。
Immunol Rev. 2007 Dec;220:102-12. doi: 10.1111/j.1600-065X.2007.00578.x.
8
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.抗原识别改变是癌症中CD8 + T细胞耐受的一种机制。
Nat Med. 2007 Jul;13(7):828-35. doi: 10.1038/nm1609. Epub 2007 Jul 1.
9
High-sensitivity detection and quantitative analysis of native protein-protein interactions and multiprotein complexes by flow cytometry.通过流式细胞术对天然蛋白质-蛋白质相互作用和多蛋白复合物进行高灵敏度检测和定量分析。
Sci STKE. 2007 Jun 5;2007(389):pl2. doi: 10.1126/stke.3892007pl2.
10
Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors.基于树突状细胞的全长生存素疫苗治疗实验性肿瘤
J Immunother. 2007 Feb-Mar;30(2):169-79. doi: 10.1097/01.cji.0000211329.83890.ba.